Agile Therapeutics Analyst Ratings
Buy Rating for Agile Therapeutics: Regulatory Tailwinds and Strong Sales Growth Forecast
Analysts Are Bullish on Top Healthcare Stocks: Mainz Biomed B.V. (MYNZ), Agile Therapeutics (AGRX)
Agile Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Rallybio (RLYB), Agile Therapeutics (AGRX) and Biomea Fusion (BMEA)
HC Wainwright & Co. Reiterates Buy on Agile Therapeutics, Maintains $12 Price Target
HC Wainwright & Co. Reiterates Buy on Agile Therapeutics, Maintains $12 Price Target
Analysts Have Conflicting Sentiments on These Healthcare Companies: Agile Therapeutics (AGRX), Check-Cap (CHEK) and Doximity (DOCS)
Maxim Group Downgrades Agile Therapeutics (AGRX) to a Hold
Maxim Group Keeps Their Buy Rating on Agile Therapeutics (AGRX)
HC Wainwright Cuts Price Target on Agile Therapeutics to $3 From $5, Maintains Buy Rating
H.C. Wainwright Sticks to Its Buy Rating for Agile Therapeutics (AGRX)
Agile Therapeutics Analyst Ratings
HC Wainwright & Co. Maintains Buy on Agile Therapeutics, Lowers Price Target to $3
Agile Therapeutics (AGRX) Gets a Buy From Maxim Group
No Data